5-hydroxytryptophan (5-HTP), a serotonin precursor, has been shown to induce LH release in female but not in male rats at 16, 18 and 20 days of age. The purpose of this study was to investigate the role of neonatal gonadal hormones on 5-HTP-induced LH release in male and female rats of 16 and 20 days of age. The following groups of rats were studied (a) control females, (b) androgenized females, (c) control males, and (d) castrated males. Androgenization and castration were performed within 48 h of birth. 5-HTP administration increased LH concentration in normal females and castrated males at 16 and 20 days of age. The LH release response to 5-HTP was significantly lower at 20 than at 16 days of age in both groups. Neonatal androgenization abolished the LH release response in prepubertal female rats. These results indicate that neonatal exposure to androgen is responsible for the sex difference in the LH response to 5-HTP, which may be associated with a regulatory action of serotonin on the cyclic hypothalamic control of gonadotrophin secretion.

Keywords:
Serotonin, Sex difference, Serotonin and puberty, Neurotransmitters and LH, Gonadotrophin and serotonin
This content is only available via PDF.
© 1987 S. Karger AG, Basel
1987
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.